Olympus Corp. Hits Day High with Strong 3.59% Intraday Surge

Olympus Corp., a prominent player in the Pharmaceuticals & Biotechnology sector, has seen a notable increase of 3.59% in its stock price on October 7, 2025. The stock reached an intraday high of JPY 1,947.00, reflecting a significant moment in its trading activity.
Despite this day's performance, Olympus Corp. has faced challenges over the past year, with a decline of 30.31%, contrasting sharply with the Japan Nikkei 225's gain of 24.09% during the same period. Year-to-date, the stock has also underperformed, showing a decrease of 19.15% compared to the index's increase of 20.18%.

On a more positive note, Olympus Corp. has demonstrated strong long-term fundamentals, highlighted by an average Return on Equity (ROE) of 18.96% and a low Debt to EBITDA ratio of 0.43 times. The company has reported positive results for the last three consecutive quarters, with operating cash flow reaching a high of JPY 152,003 million. Additionally, raw material costs have decreased by 1.66% year-over-year, contributing to its operational efficiency.

As Olympus Corp. continues to navigate the market landscape, its recent performance underscores the complexities of its financial journey.